Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 90%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,257
Total Claims
$1.2M
Drug Cost
343
Beneficiaries
$3,549
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+325%
Opioid rate vs peers
9.5% vs 2.2% avg
+152%
Cost per patient vs peers
$3,549 vs $1,411 avg
+57%
Brand preference vs peers
16.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
9.5%
Opioid Rate
881
Opioid Claims
$41K
Opioid Cost
4.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,527 claims · $1.0M
Generic: 7,637 claims · $166K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 127 | $122K |
| Dulaglutide | 105 | $118K |
| Empagliflozin | 58 | $61K |
| Semaglutide | 45 | $52K |
| Sitagliptin Phosphate | 47 | $43K |
| Apixaban | 44 | $43K |
| Liraglutide | 31 | $42K |
| Rifaximin | 12 | $41K |
| Rivaroxaban | 33 | $37K |
| Tirzepatide | 18 | $26K |
| Buprenorphine | 12 | $25K |
| Budesonide/Formoterol Fumarate | 58 | $23K |
| Insulin Lispro | 14 | $23K |
| Tiotropium Bromide | 32 | $20K |
| Linaclotide | 25 | $18K |
Prescribing Profile
Patient Profile
65
Avg Age
62%
Female
1.44
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About